During the past decade, Wojewodzki Szpital Zakazny conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojewodzki Szpital Zakazny" #1 sponsor was "Gilead Sciences" with 6 trials, followed by "Abbott" with 2 trials sponsored, "Dynavax Technologies Corporation" with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored and "University of Minnesota" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewodzki Szpital Zakazny" #1 collaborator was "Chiron Corporation" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Wojewodzki Szpital Zakazny" are "HIV Infections" (4 trials), "Chronic Hepatitis C" (3 trials), "Hepatitis B, Chronic" (3 trials), "Chronic Hepatitis B" (2 trials) and "HIV-1" (2 trials). Many other conditions were trialed in "Wojewodzki Szpital Zakazny" in a lesser frequency.

Most popular intervention types in "Wojewodzki Szpital Zakazny" are "Drug" (18 trials). Other intervention types were less common.

The name of intervention was led by "Amprenavir/ritonavir" (2 trials), "JNJ-73763989" (2 trials), "Maraviroc" (2 trials), "Placebo" (2 trials) and "Ribavirin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wojewodzki Szpital Zakazny" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Wojewodzki Szpital Zakazny". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Wojewodzki Szpital Zakazny, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewodzki Szpital Zakazny, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".